Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Millennium Hotel London Mayfair

Dec 08, 2017 9:00 AM - Dec 08, 2017 5:15 PM

44 Grosvenor Square Mayfair, London, W1K 2HP, United Kingdom

DIA Brexit Summit | Ensuring Continuity for Patients and Business

Session 5: Brexit Time Check: What’s Next for Medicines?

Session Chair(s)

Peter  O'Donnell

Peter O'Donnell

Journalist

Belgium

The aim of this session is to get to the broader level vision of what’s coming next in the Brexit schedule of change. This session will bring together a broad range of stakeholders to contribute their expectations, concerns and needs for the next stages of Brexit and the future partnership arrangements.

Speaker(s)

Robert Andrew Johnstone

Robert Andrew Johnstone

The International Foundation for Integrated Care (IFIC), United Kingdom

Patient Representative

Virginia  Acha, PhD, MSc

Virginia Acha, PhD, MSc

Merck Sharpe & Dohme LLC , United States

AVP, Global Regulatory Policy

Elizabeth  Kuiper, MA

Elizabeth Kuiper, MA

European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium

Executive Director, Public Affairs

Oliver  Sude, PhD

Oliver Sude, PhD

European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Belgium

Legal Counsel, EU Affairs

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.